HALSEY DRUG CO (OTC BB:HDGC.OB)
RE: FIGHTING ANTHRAX
THE DRUG COMPANY HALSEY PHARMACEUTICALS IS PART OF THE ACTIVE MARKET OF ANTIBIOTIC MANUFACTURERS. HALSEY PRODUCES THE DRUG DOXYCYCLINE, WHICH BELONGS TO THE DRUG CLASS CALLED TETRACYCLINE ANTIBIOTICS. DOXYCYCLINE HAS NOT ONLY BEEN PROVEN AS EFFECTIVE AS THE FAMED ANTHRAX FIGHTING DRUG CIPRO, BUT IS CHEAPER AND HAS LESS SIDE EFFECTS. (READ THE ARTICLE ON THE FORBES WEBSITE ABOUT IT)
AS A PRECAUTION, HOSPITALS AND GOVERNMENT FACILITIES HAVE RECENTLY STARTED STOCKPILING THE DRUG. THE THREAT OF ANTHRAX AND OTHER BIOLOGICAL WEAPONS HAS SPARKED A SURGE IN THE ANTIBIOTIC MARKET. (SEE:
http://www.hhs.gov/news/press/2001press/20011010a.html )
(INFORMATION ONO ANTHRAX:
http://www.cdc.gov/ncidod/diseaseinfo/anthrax_g.htm )
A RISE IN SHARE PRICE IS EXPECTED SOON FOR THE DOXYCYCLINE MAKER.
(SEE HALSEY INCOME STATEMENT:
http://biz.yahoo.com/fin/l/h/hdgc.ob.html )